Linlin Zhao

Linlin Zhao

Auto-generated profile, based on publicly available information

Linlin Zhao

The Rutgers Center for Computational and Integrative Biology, Camden, NJ 08102, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2020 in Drug Discovery Today
Verified
Journal Article
Closed access
LZLinlin Zhao
Linlin Zhao
HCHeather L. Ciallella
Heather L. Ciallella
LALauren Aleksunes
Lauren Aleksunes
HZHao Zhu
Hao Zhu

19 June 2017 in ACS Omega
Verified
Journal Article
Open access
LZLinlin Zhao
Linlin Zhao
WWWenyi Wang
Wenyi Wang
ASAlexander Sedykh
Alexander Sedykh
HZHao Zhu
Hao Zhu
Numerous chemical data sets have become available for quantitative structure–activity relationship (QSAR) modeling studies. However, the quality of different data sources may be different based on the nature of experimental protocols. Therefore, potential experimental errors in the modeling sets may lead to the development of poor QSAR models and further affect the predictions of new compounds. In this study, we explored the relationship between the ratio of questionable data in the modeling sets, which was obtained by simulating experimental errors, and the QSAR modeling performance. To this end, we used eight data sets (four continuous endpoints and four categorical endpoints) that have been extensively curated both in-house and by our collaborators to create over 1800 various QSAR models. Each data set was duplicated to create several new modeling sets with different ratios of simulated experimental errors (i.e., randomizing the activities of part of the compounds) in the modeling process. A fivefold cross-validation process was used to evaluate the modeling performance, which deteriorates when the ratio of experimental errors increases. All of the resulting models were also used to predict external sets of new compounds, which were excluded at the beginning of the modeling process. The modeling results showed that the compounds with relatively large prediction errors in cross-validation processes are likely to be those with simulated experimental errors. However, after removing a certain number of compounds with large prediction errors in the cross-validation process, the external predictions of new compounds did not show improvement. Our conclusion is that the QSAR predictions, especially consensus predictions, can identify compounds with potential experimental errors. But removing those compounds by the cross-validation procedure is not a reasonable means to improve model predictivity due to overfitting.

4 March 2021 in ACS Sustainable Chemistry & Engineering
Verified
Journal Article
Closed access
XJXuelian Jia
Xuelian Jia
HCHeather L. Ciallella
Heather L. Ciallella
DRDaniel P. Russo
Daniel P. Russo
LZLinlin Zhao
Linlin Zhao
MJMorgan H. James
Morgan H. James
HZHao Zhu
Hao Zhu

27 February 2020 in Toxicological Sciences
Verified
Journal Article
Open access
PDF file
LZLinlin Zhao
Linlin Zhao
DRDaniel P Russo
Daniel P Russo
WWWenyi Wang
Wenyi Wang
LALauren M Aleksunes
Lauren M Aleksunes
HZHao Zhu
Hao Zhu
Hepatotoxicity is a leading cause of attrition in the drug development process. Traditional preclinical and clinical studies to evaluate hepatotoxicity liabilities are expensive and time consuming. With the advent of critical advancements in high-throughput screening, there has been a rapid accumulation of in vitro toxicity data available to inform the risk assessment of new pharmaceuticals and chemicals. To this end, we curated and merged all available in vivo hepatotoxicity data obtained from the literature and public resources, which yielded a comprehensive database of 4089 compounds that includes hepatotoxicity classifications. After dividing the original database of chemicals into modeling and test sets, PubChem assay data were automatically extracted using an in-house data mining tool and clustered based on relationships between structural fragments and cellular responses in in vitro assays. The resultant PubChem assay clusters were further investigated. During the cross-validation procedure, the biological data obtained from several assay clusters exhibited high predictivity of hepatotoxicity and these assays were selected to evaluate the test set compounds. The read-across results indicated that if a new compound contained specific identified chemical fragments (ie, Molecular Initiating Event) and showed active responses in the relevant selected PubChem assays, there was potential for the chemical to be hepatotoxic in vivo. Furthermore, several mechanisms that might contribute to toxicity were derived from the modeling results including alterations in nuclear receptor signaling and inhibition of DNA repair. This modeling strategy can be further applied to the investigation of other complex chemical toxicity phenomena (eg, developmental and reproductive toxicities) as well as drug efficacy.

6 June 2017 in Environmental Science & Technology
Verified
Journal Article
Closed access
YLYin Liu
Yin Liu
GSGaoxing Su
Gaoxing Su
FWFei Wang
Fei Wang
Jianbo JiaJianbo Jia
Jianbo Jia
SLShuhuan Li
Shuhuan Li
Bing YanBing Yan
Bing Yan

Verified
Journal Article
Open access
PDF file
JXJinxiang Xi
Jinxiang Xi
Qin HuQin Hu
Qin Hu
LZLinlin Zhao
Linlin Zhao
ASApril Xiuhua Si
April Xiuhua Si
Existing in vivo experiments show significantly decreased acrolein uptake in rats with increasing inhaled acrolein concentrations. Considering that high-polarity chemicals are prone to bond with each other, it is hypothesized that molecular binding between acrolein and water will contribute to the experimentally observed deposition decrease by decreasing the effective diffusivity. The objective of this study is to quantify the probability of molecular binding for acrolein, as well as its effects on acrolein deposition, using multiscale simulations. An image-based rat airway geometry was used to predict the transport and deposition of acrolein using the chemical species model. The low Reynolds number turbulence model was used to simulate the airflows. Molecular dynamic (MD) simulations were used to study the molecular binding of acrolein in different media and at different acrolein concentrations. MD results show that significant molecular binding can happen between acrolein and water molecules in human and rat airways. With 72 acrolein embedded in 800 water molecules, about 48% of acrolein compounds contain one hydrogen bond and 10% contain two hydrogen bonds, which agreed favorably with previous MD results. The percentage of hydrogen-bonded acrolein compounds is higher at higher acrolein concentrations or in a medium with higher polarity. Computational dosimetry results show that the size increase caused by the molecular binding reduces the effective diffusivity of acrolein and lowers the chemical deposition onto the airway surfaces. This result is consistent with the experimentally observed deposition decrease at higher concentrations. However, this size increase can only explain part of the concentration-dependent variation of the acrolein uptake and acts as a concurrent mechanism with the uptake-limiting tissue ration rate. Intermolecular interactions and associated variation in diffusivity should be considered in future dosimetry modeling of high-polarity chemicals such as acrolein.